fda warning letter compounding semaglutide october 2025 Breakdown: Sterility Failures, Subpotent GLP-1 Drugs, and a Pharmacy Operating Without Control 🚨 FDA Moves to Permanently

David Rometo, M.D., a Pittsburgh-based endocrinologist and diplomat of the American Board of Obesity Medicine

RxSpan MD and any associated logos are marks of their respective owner

The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease

Lipoteichoic acid from the cell wall of a heat killed Lactobacillus paracasei D3-5 ameliorates aging-related leaky gut, inflammation and improves physical and cognitive functions: from C

However, in a study by Bezin and colleagues (2023), the use of GLP-1 RA for 1-3 years was associated with an increased risk of thyroid cancer and medullary thyroid cancer

Quality considerations for compounded formulations If you are using compounded semaglutide with glycine, the quality of your formulation depends entirely on the pharmacy that produces it